Charles Schwab’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-92,904
| Closed | -$1.06M | – | 3549 |
|
|
2020
Q4 | $1.06M | Buy |
92,904
+1,461
| +2% | +$16.6K | ﹤0.01% | 2754 |
|
|
2020
Q3 | $631K | Buy |
91,443
+613
| +0.7% | +$4.02K | ﹤0.01% | 2816 |
|
|
2020
Q2 | $593K | Sell |
90,830
-1,249
| -1% | -$8.06K | ﹤0.01% | 2770 |
|
|
2020
Q1 | $609K | Buy |
92,079
+1,758
| +2% | +$15.3K | ﹤0.01% | 2647 |
|
|
2019
Q4 | $937K | Buy |
90,321
+990
| +1% | +$8.47K | ﹤0.01% | 2619 |
|
|
2019
Q3 | $565K | Sell |
89,331
-14,560
| -14% | -$109K | ﹤0.01% | 2755 |
|
|
2019
Q2 | $773K | Buy |
103,891
+23,760
| +30% | +$157K | ﹤0.01% | 2662 |
|
|
2019
Q1 | $493K | Sell |
80,131
-4,076
| -5% | -$47.2K | ﹤0.01% | 2776 |
|
|
2018
Q4 | $971K | Sell |
84,207
-1,490
| -2% | -$25.4K | ﹤0.01% | 2548 |
|
|
2018
Q3 | $1.86M | Buy |
85,697
+14,370
| +20% | +$272K | ﹤0.01% | 2448 |
|
|
2018
Q2 | $1.12M | Buy |
71,327
+15,675
| +28% | +$246K | ﹤0.01% | 2557 |
|
|
2018
Q1 | $1.05M | Buy |
55,652
+1,872
| +3% | +$36.9K | ﹤0.01% | 2501 |
|
|
2017
Q4 | $936K | Sell |
53,780
-11,881
| -18% | -$164K | ﹤0.01% | 2529 |
|
|
2017
Q3 | $983K | Buy |
65,661
+26,529
| +68% | +$417K | ﹤0.01% | 2513 |
|
|
2017
Q2 | $726K | Buy |
39,132
+285
| +0.7% | +$4.95K | ﹤0.01% | 2570 |
|
|
2017
Q1 | $656K | Buy |
38,847
+2,565
| +7% | +$51.2K | ﹤0.01% | 2554 |
|
|
2016
Q4 | $773K | Buy |
36,282
+2,310
| +7% | +$47.4K | ﹤0.01% | 2505 |
|
|
2016
Q3 | $621K | Buy |
33,972
+10,563
| +45% | +$238K | ﹤0.01% | 2549 |
|
|
2016
Q2 | $679K | Buy |
+23,409
| New | +$651K | ﹤0.01% | 2481 |
|
Charles Schwab's ARA Position: Q1 2021 in Review
Charles Schwab sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 92,904 shares — an estimated $1.06M sold.
Charles Schwab first reported a position in ARA in Q2 2016 and held it in 19 quarters. The position peaked at $1.86M in Q3 2018. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.
- Charles Schwab reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
- Charles Schwab sold 92,904 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $1.06M.
- Charles Schwab first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 19 quarters.
- Charles Schwab's American Renal Associates Holdings, Inc position peaked at $1.86M in Q3 2018.
- 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.
Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.